DRL posts consolidated revenues of Rs 37.6 billion, showing seven per cent growth YoY Gross profit margin were at 61.1 per cent July 31, 2015 11:48 IST
Dr Reddy’s shares rise on generic dementia drug launch in US Dr Reddy’s shares rose as much as 1.9 per cent to a record high after the company launched the generic… July 14, 2015 12:27 IST
DRL announces launch of memantine hydrochloride tablets, USP It is a therapeutic equivalent generic version of NAMENDA (memantine HCl) tablets in the US market July 13, 2015 17:51 IST
DRL files Annual Report on Form 20-F The report was filed with the United States Securities and Exchange Commission recently June 18, 2015 16:13 IST
Satish Reddy takes over as National Safety Council Chairman Reddy takes over the Chairmanship from Venu Srinivasan, who steered the workings of the Council since July 2011 June 12, 2015 19:27 IST
DRL in agreement with AstraZeneca Pharma India for Riax and Riax M DRL will be distributing Riax and Riax M in India Dr Reddy’s Laboratories (DRL) and AstraZeneca Pharma India have entered… June 1, 2015 11:10 IST
Satish Reddy appointed as Chairman of National Safety Council He will take over the Chairmanship from Venu Srinivasan, who steered the workings of the Council since July 2011 May 21, 2015 09:30 IST
‘Buy’ rating on Dr Reddy’s Lab: Weathering multiple headwinds Well-placed to deliver growth once US approvals pick up May 18, 2015 00:08 IST
DRL launches Somazina for stroke patients in India Partners with global innovator of Citicoline, Ferrer Internacional, Spain, to make Somazina available in India May 15, 2015 17:10 IST
DRL Q4 net rises 8% on higher sales Buoyed by higher sale of generics and new product launches, Dr Reddy’s Laboratories (DRL) has reported a consolidated net profit… May 13, 2015 01:20 IST
Satish Reddy appointed as Chairman of National Safety Council He will take over the Chairmanship from Venu Srinivasan, who steered the workings of the Council since July 2011 May 12, 2015 13:46 IST
DRL, Promius Pharma files NDAs with US FDA Dr Reddy’s Laboratories and its subsidiary, Promius Pharma announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the… April 21, 2015 16:05 IST
Buy DRL as UCB buy incrementally positive Reiterate ‘buy’ on Dr Reddy’s Laboratories and value the stock at 20x FY17 EPS forecast of Rs 177.5, which derives… April 9, 2015 02:49 IST
DRL and its subsidiary Promius Pharma files three NDAs with US FDA The three NDAs – DFD-01, DFD-09, and DFN-11, are in support of Dr Reddy’s Proprietary Products group Updated: April 8, 2015 15:02 IST
DRL to acquire select portfolio of UCB’s products business in India The revenues of the acquired business is approximately Rs 150 crores for calendar year 2014 April 2, 2015 11:41 IST
Dr Reddy’s Labs to buy select UCB brands for Rs 800 crore Dr Reddy’s Laboratories has decided to buy select established brands of Belgium-based UCB… Updated: April 2, 2015 01:23 IST
Dr Reddy’s Laboratories to buy UCB’s select brands for Rs 800 crore Drug firm Dr Reddy’s Laboratories will acquire select portfolio of established brands of Belgian firm UCB in India, Nepal, Sri… April 1, 2015 14:07 IST
DRL in partnership with Hetero To accelerate access to treatment for Hepatitis C in India Updated: March 23, 2015 19:17 IST
Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs
Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps
India vs Pakistan, Asia Cup 2025: From Gill to Afridi, 8 key players to watch out for in the Dubai thriller – In pictures 4 weeks agoSeptember 13, 2025